IL17A and colorectal carcinoma: It is also reported that IL-17 perpetuate CRC progression via promoting angiogenesis and the IL-17/IL-23 pathway plays a critical role in pathogenesis of CRC (IL-23 is a key modulator of IL-17 γδ T cells responses) (12) (Figure 1).